If the $2 trln rocket company used nonvoting stock in a deal, Elon Musk would control an enlarged hype-fueled conglomerate. Hedging robo-taxi and CEO-attention risks also should appeal to the ...
A do-it-all digital assistant consumes more computation than a chatbot. To cover the expense, boss Mark Zuckerberg may need ...
One of Europe’s most cheaply valued drugmakers, the £75 bln group run by Luke Miels is turning a corner. Fears over expiring patents are easing thanks to a booming oncology unit. A £40 bln sales ...
Shares in EssilorLuxottica jumped 14% after a strong quarter, but remain 47% below their peak. Hopes that a smartglasses partnership with Meta would magnify profits have given way to fears it may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results